東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Construction of a Simian Immunodefic...

Russell, Justen Norman Hoffman.

FindBook

Google Book

Amazon

博客來

Construction of a Simian Immunodeficiency Virus Vaccine from Cynomolgus Macaque Cytomegalovirus.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Construction of a Simian Immunodeficiency Virus Vaccine from Cynomolgus Macaque Cytomegalovirus./
作者:	Russell, Justen Norman Hoffman.
出版者:	Ann Arbor : ProQuest Dissertations & Theses, : 2018,
面頁冊數:	213 p.
附註:	Source: Dissertations Abstracts International, Volume: 80-02, Section: B.
Contained By:	Dissertations Abstracts International80-02B.
標題:	Biology. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10789304
ISBN:	9780438190375

Construction of a Simian Immunodeficiency Virus Vaccine from Cynomolgus Macaque Cytomegalovirus.
Russell, Justen Norman Hoffman.

Construction of a Simian Immunodeficiency Virus Vaccine from Cynomolgus Macaque Cytomegalovirus. - Ann Arbor : ProQuest Dissertations & Theses, 2018 - 213 p.

Source: Dissertations Abstracts International, Volume: 80-02, Section: B.

Thesis (Ph.D.)--University of Toronto (Canada), 2018.

This item must not be sold to any third party vendors.

The current HIV pandemic has killed more than 35 million people since 1985, and infects a further 30 million globally. Vaccines based on herpesvirus vectors, in particular cytomegalovirus, generate unique, robust immune responses that may overcome many of the typical obstacles to an effective preventative HIV vaccine. Recent studies using a cytomegalovirus based vaccine in the rhesus macaque monkey model have protected close to half of all vaccinated monkeys from SIV, but questions remain as to the mechanism of protection and whether similar results will be seen in humans against HIV. These questions may be answerable through the use of the cynomolgus macaque monkey model, and a minimally passaged cytomegalovirus vector that more closely resembles human cytomegalovirus. To this end a novel cytomegalovirus was isolated from a Mauritian cynomolgus macaque monkey. This virus was sequenced in full and phylogenetically characterized alongside other primate cytomegaloviruses and their hosts. To generate a vaccine construct the newly isolated and minimally passaged cynomolgus macaque cytomegalovirus was first cloned as a bacterial artificial chromosome (BAC) to facilitate the preservation of the virus without further accumulation of attenuations from in vitro passaging. After sequencing the BAC, and comparison of the growth kinetics of the viruses derived from the BAC to determine if there was an observed in vitro loss of fitness, the BAC was used to construct a vaccine against SIV. This new cynomolgus macaque cytomegalovirus based SIV vaccine for use in cynomolgus macaques retains wildtype growth kinetics in vitro. It is the first cytomegalovirus based SIV vaccine for use in the cynomolgus macaque model and the first cytomegalovirus used in vaccine studies that purposely has been generated with a focus on retention of viral fitness. This is a valuable molecular tool that will permit the further understanding of herpesviruses as vaccine vectors and their potential application in humans.

ISBN: 9780438190375Subjects--Topical Terms:

522710
Biology.

Construction of a Simian Immunodeficiency Virus Vaccine from Cynomolgus Macaque Cytomegalovirus.
LDR:03147nmm a2200337 4500 001 2210349
005 20191121124207.5
008 201008s2018 ||||||||||||||||| ||eng d
020 $a 9780438190375
035 $a (MiAaPQ)AAI10789304
035 $a (MiAaPQ)toronto:17426
035 $a AAI10789304
040 $a MiAaPQ $c MiAaPQ
100 1 $a Russell, Justen Norman Hoffman. $3 3437491
245 1 0 $a Construction of a Simian Immunodeficiency Virus Vaccine from Cynomolgus Macaque Cytomegalovirus.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2018
300 $a 213 p.
500 $a Source: Dissertations Abstracts International, Volume: 80-02, Section: B.
500 $a Publisher info.: Dissertation/Thesis.
500 $a Advisor: MacDonald, Kelly S.
502 $a Thesis (Ph.D.)--University of Toronto (Canada), 2018.
506 $a This item must not be sold to any third party vendors.
520 $a The current HIV pandemic has killed more than 35 million people since 1985, and infects a further 30 million globally. Vaccines based on herpesvirus vectors, in particular cytomegalovirus, generate unique, robust immune responses that may overcome many of the typical obstacles to an effective preventative HIV vaccine. Recent studies using a cytomegalovirus based vaccine in the rhesus macaque monkey model have protected close to half of all vaccinated monkeys from SIV, but questions remain as to the mechanism of protection and whether similar results will be seen in humans against HIV. These questions may be answerable through the use of the cynomolgus macaque monkey model, and a minimally passaged cytomegalovirus vector that more closely resembles human cytomegalovirus. To this end a novel cytomegalovirus was isolated from a Mauritian cynomolgus macaque monkey. This virus was sequenced in full and phylogenetically characterized alongside other primate cytomegaloviruses and their hosts. To generate a vaccine construct the newly isolated and minimally passaged cynomolgus macaque cytomegalovirus was first cloned as a bacterial artificial chromosome (BAC) to facilitate the preservation of the virus without further accumulation of attenuations from in vitro passaging. After sequencing the BAC, and comparison of the growth kinetics of the viruses derived from the BAC to determine if there was an observed in vitro loss of fitness, the BAC was used to construct a vaccine against SIV. This new cynomolgus macaque cytomegalovirus based SIV vaccine for use in cynomolgus macaques retains wildtype growth kinetics in vitro. It is the first cytomegalovirus based SIV vaccine for use in the cynomolgus macaque model and the first cytomegalovirus used in vaccine studies that purposely has been generated with a focus on retention of viral fitness. This is a valuable molecular tool that will permit the further understanding of herpesviruses as vaccine vectors and their potential application in humans.
590 $a School code: 0779.
650 4 $a Biology. $3 522710
650 4 $a Virology. $3 642304
650 4 $a Immunology. $3 611031
690 $a 0306
690 $a 0720
690 $a 0982
710 2 $a University of Toronto (Canada). $b Immunology. $3 3193210
773 0 $t Dissertations Abstracts International $g 80-02B.
790 $a 0779
791 $a Ph.D.
792 $a 2018
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10789304